Tembexa is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Chimerix, Inc.. The primary component is Brincidofovir.
Product ID | 79622-010_179ef983-ea03-496a-be62-7ce509cea793 |
NDC | 79622-010 |
Product Type | Human Prescription Drug |
Proprietary Name | Tembexa |
Generic Name | Brincidofovir |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2022-04-20 |
Marketing Category | NDA / |
Application Number | NDA214461 |
Labeler Name | Chimerix, Inc. |
Substance Name | BRINCIDOFOVIR |
Active Ingredient Strength | 100 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-04-20 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
79622-010 | Tembexa | Brincidofovir |
79622-012 | Tembexa | Brincidofovir |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() TEMBEXA 86800892 4996484 Live/Registered |
Chimerix UK Limited 2015-10-27 |